Clinical Trial Update: The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis

View source ↗

Summary

Clinical trial update on dupilumab evaluating its effect on anxiety and depression symptoms in patients with moderate-to-severe atopic dermatitis; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Status: RECRUITING